Arantxa Horga

Oral Bemnifosbuvir (AT-527) Vs Placebo in Patients With mild-to-moderate COVID-19 in an Outpatient Setting (MORNINGSKY)

Arantxa Horga, Rebecca Saenz, Gürdal Yılmaz et al. · Future Virology · 2023 · 19 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

First-in-human trial evaluating safety and pharmacokinetics of AT-752, a novel nucleotide prodrug with pan-serotype activity against dengue virus

Xiao-Jian Zhou, Jason D. Lickliter, Maureen Montrond et al. · Antimicrobial Agents and Chemotherapy · 2024 · 13 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Phase II Study of Bemnifosbuvir in High-Risk Participants in a Hospital Setting with Moderate COVID-19

Arantxa Horga, Daniel R. Kuritzkes, John J. Kowalczyk et al. · Future Virology · 2023 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

A Phase 2 Randomized Trial Evaluating the Antiviral Activity and Safety of the Direct-Acting Antiviral Bemnifosbuvir in Ambulatory Patients with Mild or Moderate COVID-19 (MOONSONG Study)

Marta Boffito, Eamon Dolan, Karishma Singh et al. · Microbiology Spectrum · 2023 · 11 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +17